Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by taman1on May 06, 2016 6:11pm
308 Views
Post# 24849704

From .54 to .35 in a couple of weeks sucks

From .54 to .35 in a couple of weeks sucksand knowing it is because of Hodge and his followers who wanted to sell at .60 at a great profit but now in the .40s and .30s instead gave me some comfort.
Why Arun did not do a NR befuddle us all. Why he did an NR later on a drug without mentioning the financials befuddle many more. The financial indicated better thiings are ahead. Another 3 more months for validation with the ARs and sales hirings and steady working capital.
We must assume Arun has his reasons and if his sales for this year is over $8 million as most of us projected and NPH becomes profitable with no more dilution to shares. Arun will be the hero and this hiccup will be history and we will be smiling.
Hodge is an opportunist and capitalist like all of us here. The only difference he is out and we are still in. Who makes more money in the long run, I beleve we will. This is now a 2Q story and if it is any comfort I had no plans to sell at .60, so if it had hit .60 it would just be a floating gain versus now a floating loss once more  .. GLTA .. Cheers
Bullboard Posts